Bristol Myers Squibb (NYSE: BMY) reported its third quarter 2025 earnings outcomes in the present day.
Revenues elevated 3% year-over-year to $12.2 billion.
GAAP web revenue attributable to Bristol Myers Squibb was $2.2 billion, or $1.08 per share, in comparison with $1.2 billion, or $0.60 per share, final 12 months. Adjusted EPS was $1.63, down 9% YoY.
For full-year 2025, income is anticipated to be $47.5-48.0 billion. Adjusted EPS is anticipated to be $6.40-6.60.
Prior efficiency
